US · Healthcare

CanSino Biologics Inc (CASBF)

Drug Manufacturers - Specialty & Generic

CanSino Biologics Inc (CASBF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CASBF

P/E ratio

18.00

CanSino Biologics Inc (CASBF) — FAQ

What is CASBF's P/E ratio?

The price-to-earnings (P/E) ratio for CanSino Biologics Inc (CASBF) is 18.00 (data as of 2026-03-23).

Does CanSino Biologics Inc pay a dividend?

Dividend yield is not available in the current snapshot for CanSino Biologics Inc (CASBF). Check the MyAverix Finance app for the latest dividend data.

What sector is CanSino Biologics Inc in?

CanSino Biologics Inc (CASBF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CASBF listed on?

CASBF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)